- Home
- ABUS vs ITRG Comparison
ABUS vs ITRG Comparison
Compare ABUS & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABUS | ITRG |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 884.7M | 874.5M |
| IPO Year | 2008 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ABUS | ITRG |
|---|---|---|
| Price | $4.71 | $3.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $5.13 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,171,000.00 | N/A |
| Revenue This Year | $125.30 | $733.38 |
| Revenue Next Year | N/A | $46.00 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.71 | $1.05 |
| 52 Week High | $5.10 | $4.87 |
Technical Indicators
Market Signals| Indicator | ABUS | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 43.57 |
| Support Level | $4.18 | $3.27 |
| Resistance Level | $5.01 | $4.56 |
| Average True Range (ATR) | 0.22 | 0.23 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 80.79 | 23.00 |
Price Performance
Historical ComparisonAbout ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.